与脏的超能代谢相关的capivasertib治疗
Maria Ly1, Gary Z Yu1, Amin Haghighat Jahromi2,3
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA.
EJNMMI reports
|March 24, 2025
概括
对于晚期癌症的capivasertib治疗可能会导致脏过度代谢,这是[18F]-FDG PET/CT扫描的发现. 放射科医生应该意识到这种潜在的与治疗相关的成像发现.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 核医学就是核医学.
背景情况:
- Capivasertib 是一种针对晚期乳腺癌和前列腺癌的试验性治疗方法.
- 氧葡萄糖正子发射断层扫描/计算机断层扫描 ([18F]-FDG PET/CT) 是癌症管理中的一个关键的成像模式.
研究的目的:
- 报告第一个记录下来的脊髓超新陈代谢病例,该病例在 [18F]-FDG PET/CT 上观察到,该病例是在 capivasertib 治疗后出现的.
- 提高放射科医生对这种潜在的治疗相关成像发现的认识.
主要方法:
- 两名患有转移性乳腺癌的患者用capivasertib治疗的病例报告.
- [18F]-FDG PET/CT扫描在卡皮瓦塞蒂布治疗期间进行的审查.
主要成果:
- 两位患者在开始服用capivasertib后,在PET/CT扫描上显示[18F]-FDG的脏吸收增加.
- 这种脏超新陈代谢是一种与capivasertib治疗相关的以前未被描述的现象.
结论:
- 在[18F]-FDG PET/CT上脏过度代谢是capivasertib治疗的潜在副作用.
- 放射科医生解释[18F]-FDG PET/CT扫描在capivasertib患者应该考虑这一发现.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
123
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
123
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
145
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
145